NASDAQ
Century Therapeutics, Inc. (IPSC) has a free cash flow growth of -57.53% as of Friday, May 29, 2026. This represents a 1175.50% decrease compared to its 12-month average of 5.35%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.